CI Quote, Financials, Valuation and Earnings

Centene has a net margin of 2.02% compared to The Cigna Group's net margin of 2.81%. The Cigna Group's return on equity of 12.17% beat Centene's return on equity of 12.65%.

The Cigna Group has a consensus price target of $375.21, signalling upside risk potential of 18.5%. On the other hand Centene has an analysts' consensus of $78.09 which suggests that it could grow by 38.37%. Given that Centene has higher upside potential than The Cigna Group, analysts believe Centene is more attractive than The Cigna Group.

The Cigna Group has a beta of 0.472, which suggesting that the stock is 52.821% less volatile than S&P 500. In comparison Centene has a beta of 0.478, suggesting its less volatile than the S&P 500 by 52.18%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.8%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cigna Group pays 45.63% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.5B, which are larger than Centene quarterly revenues of $46.6B. The Cigna Group's net income of $1.3B is higher than Centene's net income of $1.3B. Notably, The Cigna Group's price-to-earnings ratio is 17.53x while Centene's PE ratio is 8.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.35x versus 0.17x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 2.02% compared to The Cigna Group's net margin of 4.47%. The Cigna Group's return on equity of 12.17% beat Elevance Health's return on equity of 14.03%.

The Cigna Group has a consensus price target of $375.21, signalling upside risk potential of 18.5%. On the other hand Elevance Health has an analysts' consensus of $503.49 which suggests that it could grow by 31.17%. Given that Elevance Health has higher upside potential than The Cigna Group, analysts believe Elevance Health is more attractive than The Cigna Group.

The Cigna Group has a beta of 0.472, which suggesting that the stock is 52.821% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.657, suggesting its less volatile than the S&P 500 by 34.296%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.8%. Elevance Health offers a yield of 1.72% to investors and pays a quarterly dividend of $1.71 per share. The Cigna Group pays 45.63% of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.5B, which are larger than Elevance Health quarterly revenues of $48.9B. The Cigna Group's net income of $1.3B is lower than Elevance Health's net income of $2.2B. Notably, The Cigna Group's price-to-earnings ratio is 17.53x while Elevance Health's PE ratio is 14.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.35x versus 0.48x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 2.02% compared to The Cigna Group's net margin of 2.67%. The Cigna Group's return on equity of 12.17% beat Molina Healthcare's return on equity of 25.66%.

The Cigna Group has a consensus price target of $375.21, signalling upside risk potential of 18.5%. On the other hand Molina Healthcare has an analysts' consensus of $360.24 which suggests that it could grow by 18.1%. Given that The Cigna Group has higher upside potential than Molina Healthcare, analysts believe The Cigna Group is more attractive than Molina Healthcare.

The Cigna Group has a beta of 0.472, which suggesting that the stock is 52.821% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.702%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.8%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cigna Group pays 45.63% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.5B, which are larger than Molina Healthcare quarterly revenues of $11.1B. The Cigna Group's net income of $1.3B is higher than Molina Healthcare's net income of $298M. Notably, The Cigna Group's price-to-earnings ratio is 17.53x while Molina Healthcare's PE ratio is 14.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.35x versus 0.41x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 2.02% compared to The Cigna Group's net margin of 5.74%. The Cigna Group's return on equity of 12.17% beat UnitedHealth Group's return on equity of 21.74%.

The Cigna Group has a consensus price target of $375.21, signalling upside risk potential of 18.5%. On the other hand UnitedHealth Group has an analysts' consensus of $397.36 which suggests that it could grow by 31.62%. Given that UnitedHealth Group has higher upside potential than The Cigna Group, analysts believe UnitedHealth Group is more attractive than The Cigna Group.

The Cigna Group has a beta of 0.472, which suggesting that the stock is 52.821% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.561, suggesting its less volatile than the S&P 500 by 43.865%.

The Cigna Group has a quarterly dividend of $1.51 per share corresponding to a yield of 1.8%. UnitedHealth Group offers a yield of 2.78% to investors and pays a quarterly dividend of $2.10 per share. The Cigna Group pays 45.63% of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cigna Group quarterly revenues are $65.5B, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. The Cigna Group's net income of $1.3B is lower than UnitedHealth Group's net income of $6.3B. Notably, The Cigna Group's price-to-earnings ratio is 17.53x while UnitedHealth Group's PE ratio is 12.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cigna Group is 0.35x versus 0.68x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.